Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in hematology and immunology. We are now enrolling our VIVID clinical trials studying VGA039 in patients with VWD. Please visit us at Booth #108.
Star Therapeutics is a biotechnology company that interrogates areas of novel biology to develop life-changing therapies, initially addressing unmet needs in hematology and immunology. Our innovation engine starts with identifying diseases that share common biology and then discovering novel therapeutics to treat these diseases. Star consists of a constellation of companies, each focused on a specific area of biology with first-in-class therapies. Please visit us at www.star-therapeutics.com